Title:
【発明の名称】ヒトVEGF-特異的アンチセンスオリゴヌクレオチド
Document Type and Number:
Japanese Patent JPH11501508
Kind Code:
A
Abstract:
Disclosed are oligonucleotides complementary to VEGF-specific nucleic acid useful in reducing the expression of VEGF. Also disclosed are pharmaceutical formulations containing such oligonucleotides and method useful for treating various disorders associated with neovascularization and angiogenesis.
Inventors:
Robinson, Gregory Es
Application Number:
JP52643196A
Publication Date:
February 09, 1999
Filing Date:
February 29, 1996
Export Citation:
Assignee:
HYBRIDON,INC.
International Classes:
A61K31/70; A61K31/7088; C12N15/09; A61K48/00; A61P3/08; A61P9/00; A61P9/10; A61P17/00; A61P27/02; A61P35/00; C07H21/02; C07H21/04; C12N5/02; C12N15/113; A61K38/00; (IPC1-7): C12N15/09; A61K31/70; A61K48/00
Attorney, Agent or Firm:
Aoyama Ryo (1 person outside)
Previous Patent: ヒトインターロイキン−１β変換酵素のアイソフォームおよび同アイソフ...
Next Patent: ｔ（１４：１８）転座を有する腫瘍細胞に関連するアンチセンス転写産物...
Next Patent: ｔ（１４：１８）転座を有する腫瘍細胞に関連するアンチセンス転写産物...